SBP solbec pharmaceuticals limited

The company with Nexavar. Approved for liver cancer. On the news...

  1. 5,996 Posts.
    lightbulb Created with Sketch. 162
    The company with Nexavar. Approved for liver cancer. On the news of the success the stock rose from $12 to $57 over the year. That is a market cap of just over $3Billion.
    Success against liver cancer would see SBP go ballistic.
    Have a happy and prosperous new year.
    http://moneycentral.msn.com/investor/charts/chartdl.aspx?Symbol=ONXX&D4=1&ViewType=0&&ShowChtBt=Refresh+Chart&DateRangeForm=1&ComparisonsForm=1&D5=0&CP=0&PT=5&CE=0&3=0&PeriodType=5&C9=0&DisplayForm=1
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.